Advisory Committees

Briefing Information for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

Janssen Pharmaceuticals, Inc.

Disclaimer: The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Page Last Updated: 09/04/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.